Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Common and different neural markers in major depression and anxiety disorders: A pilot structural magnetic resonance imaging study.

Eleonora M, Giuseppe D, Marika G, Marco G, Sara P, Carolina B, Marta M, Serena D, Giampaolo P, Matteo B, Paolo B.

Psychiatry Res Neuroimaging. 2019 Aug 30;290:42-50. doi: 10.1016/j.pscychresns.2019.06.006. Epub 2019 Jun 26.

PMID:
31279954
2.

Visibility and representation of women in multiple sclerosis research.

Thomson A, Horne R, Chung C, Marta M, Giovannoni G, Palace J, Dobson R.

Neurology. 2019 Apr 9;92(15):713-719. doi: 10.1212/WNL.0000000000007276. Epub 2019 Mar 20. Review.

3.

Intramedullary nailing biomechanics: Evolution and challenges.

Rosa N, Marta M, Vaz M, Tavares SMO, Simoes R, Magalhães FD, Marques AT.

Proc Inst Mech Eng H. 2019 Mar;233(3):295-308. doi: 10.1177/0954411919827044.

PMID:
30887900
4.

Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies.

Mao Z, Álvarez-González C, Allen-Philbey K, De Trane S, Yildiz O, Campion T, Adams A, Turner BP, Marta M, Gnanapavan S, Espasandin M, Mathews J, Giovannoni G, Baker D, Schmierer K.

Mult Scler Relat Disord. 2019 Jan;27:247-253. doi: 10.1016/j.msard.2018.11.001. Epub 2018 Nov 2.

PMID:
30419510
5.

Inclusion criteria used in trials of people with progressive multiple sclerosis.

Dubuisson N, Marta M, Gnanapavan S, Turner B, Baker D, Thomson A, Schmierer K, Giovannoni G.

Mult Scler. 2018 Oct 15:1352458518803769. doi: 10.1177/1352458518803769. [Epub ahead of print] No abstract available.

PMID:
30318994
6.

No evidence of disease activity in people with multiple sclerosis.

Marta M.

Eur J Neurol. 2019 Jan;26(1):1-2. doi: 10.1111/ene.13771. Epub 2018 Aug 31. No abstract available.

PMID:
30102815
7.

Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?

Mao Z, Álvarez-Gonzalez C, De Trane S, Yildiz O, Albor C, Doctor G, Soon D, Pepper G, Turner BP, Marta M, Mathews J, Giovannoni G, Baker D, Schmierer K.

Mult Scler J Exp Transl Clin. 2018 Jun 26;4(2):2055217318783767. doi: 10.1177/2055217318783767. eCollection 2018 Apr-Jun.

8.

A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study.

Gold J, Marta M, Meier UC, Christensen T, Miller D, Altmann D, Holden D, Bianchi L, Adiutori R, MacManus D, Yousry T, Schmierer K, Turner B, Giovannoni G.

Mult Scler Relat Disord. 2018 Aug;24:123-128. doi: 10.1016/j.msard.2018.06.002. Epub 2018 Jun 28.

PMID:
29990894
9.

Alemtuzumab depletion failure can occur in multiple sclerosis.

Dubuisson N, Baker D, Kang AS, Pryce G, Marta M, Visser LH, Hofmann WE, Gnanapavan S, Giovannoni G, Schmierer K.

Immunology. 2018 Jun;154(2):253-260. doi: 10.1111/imm.12879. Epub 2018 Jan 4.

10.

Recent developments on intramedullary nailing: a biomechanical perspective.

Rosa N, Marta M, Vaz M, Tavares SMO, Simoes R, Magalhães FD, Marques AT.

Ann N Y Acad Sci. 2017 Nov;1408(1):20-31. doi: 10.1111/nyas.13524. Epub 2017 Nov 1. Review.

PMID:
29090836
11.

Validation of an environmentally-friendly and affordable cardboard 9-hole peg test.

Dubuisson N, Bauer A, Buckley M, Gilbert R, Paterson A, Marta M, Gnanapavan S, Turner B, Baker D, Giovannoni G, Schmierer K, Thomson A.

Mult Scler Relat Disord. 2017 Oct;17:172-176. doi: 10.1016/j.msard.2017.08.002. Epub 2017 Aug 9.

PMID:
29055452
12.

Disease modification in advanced MS: Focus on upper limb function.

Dubuisson N, Baker D, Thomson A, Marta M, Gnanapavan S, Turner B, Giovannoni G, Schmierer K.

Mult Scler. 2017 Dec;23(14):1956-1957. doi: 10.1177/1352458517717811. Epub 2017 Jul 3. No abstract available.

PMID:
28669257
13.

Cytoprotective action against oxidative stress in astrocytes and neurons by Bactris guineensis (L.) H.E. Moore (corozo) fruit extracts.

López S, Martá M, Sequeda LG, Celis C, Sutachan JJ, Albarracín SL.

Food Chem Toxicol. 2017 Nov;109(Pt 2):1010-1017. doi: 10.1016/j.fct.2017.04.025. Epub 2017 Apr 22.

14.

Impact of Joint Involvement on Patients Reported Outcomes in Systemic Lupus Erythematosus.

Chiara T, Linda C, Andrea DS, Lucrezia R, Sabrina V, Rosaria T, Alessandra DR, Chiara B, Stefano B, Marta M.

Curr Rheumatol Rev. 2018;14(2):188-192. doi: 10.2174/1573397113666170314110022.

PMID:
28292254
15.

Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis.

Baker D, Marta M, Pryce G, Giovannoni G, Schmierer K.

EBioMedicine. 2017 Feb;16:41-50. doi: 10.1016/j.ebiom.2017.01.042. Epub 2017 Jan 31. Review.

16.

Proton Distribution Radii of ^{12-19}C Illuminate Features of Neutron Halos.

Kanungo R, Horiuchi W, Hagen G, Jansen GR, Navratil P, Ameil F, Atkinson J, Ayyad Y, Cortina-Gil D, Dillmann I, Estradé A, Evdokimov A, Farinon F, Geissel H, Guastalla G, Janik R, Kimura M, Knöbel R, Kurcewicz J, Litvinov YA, Marta M, Mostazo M, Mukha I, Nociforo C, Ong HJ, Pietri S, Prochazka A, Scheidenberger C, Sitar B, Strmen P, Suzuki Y, Takechi M, Tanaka J, Tanihata I, Terashima S, Vargas J, Weick H, Winfield JS.

Phys Rev Lett. 2016 Sep 2;117(10):102501. doi: 10.1103/PhysRevLett.117.102501. Epub 2016 Sep 2.

PMID:
27636470
17.

First Measurement of Several β-Delayed Neutron Emitting Isotopes Beyond N=126.

Caballero-Folch R, Domingo-Pardo C, Agramunt J, Algora A, Ameil F, Arcones A, Ayyad Y, Benlliure J, Borzov IN, Bowry M, Calviño F, Cano-Ott D, Cortés G, Davinson T, Dillmann I, Estrade A, Evdokimov A, Faestermann T, Farinon F, Galaviz D, García AR, Geissel H, Gelletly W, Gernhäuser R, Gómez-Hornillos MB, Guerrero C, Heil M, Hinke C, Knöbel R, Kojouharov I, Kurcewicz J, Kurz N, Litvinov YA, Maier L, Marganiec J, Marketin T, Marta M, Martínez T, Martínez-Pinedo G, Montes F, Mukha I, Napoli DR, Nociforo C, Paradela C, Pietri S, Podolyák Z, Prochazka A, Rice S, Riego A, Rubio B, Schaffner H, Scheidenberger Ch, Smith K, Sokol E, Steiger K, Sun B, Taín JL, Takechi M, Testov D, Weick H, Wilson E, Winfield JS, Wood R, Woods P, Yeremin A.

Phys Rev Lett. 2016 Jul 1;117(1):012501. doi: 10.1103/PhysRevLett.117.012501. Epub 2016 Jun 29.

PMID:
27419564
18.

Switching patients at high risk of PML from natalizumab to another disease-modifying therapy.

Giovannoni G, Marta M, Davis A, Turner B, Gnanapavan S, Schmierer K.

Pract Neurol. 2016 Oct;16(5):389-93. doi: 10.1136/practneurol-2015-001355. Epub 2016 Apr 25.

PMID:
27114560
19.

Recurrent cerebrospinal fluid escape in an HIV-1-infected patient receiving antiretroviral therapy.

Martins J, Santos E, Salgado P, Maia L, Dias D, Marta M, França M.

AIDS. 2016 Apr 24;30(7):1143-4. doi: 10.1097/QAD.0000000000001037. No abstract available.

PMID:
27028145
20.

A brief history of the evolution of the medical research article.

Marta MM.

Clujul Med. 2015;88(4):567-70. doi: 10.15386/cjmed-560. Epub 2015 Nov 15.

21.

IgG4-related disease: a rare but treatable cause of refractory intracranial hypertension.

Williams T, Marta M, Giovannoni G.

Pract Neurol. 2016 Jun;16(3):235-9. doi: 10.1136/practneurol-2015-001275. Epub 2015 Dec 11.

PMID:
26657781
22.

No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine.

Pakpoor J, Disanto G, Altmann DR, Pavitt S, Turner BP, Marta M, Juliusson G, Baker D, Chataway J, Schmierer K.

Neurol Neuroimmunol Neuroinflamm. 2015 Oct 1;2(6):e158. doi: 10.1212/NXI.0000000000000158. eCollection 2015 Dec.

23.

Is it time to target no evident disease activity (NEDA) in multiple sclerosis?

Giovannoni G, Turner B, Gnanapavan S, Offiah C, Schmierer K, Marta M.

Mult Scler Relat Disord. 2015 Jul;4(4):329-33. doi: 10.1016/j.msard.2015.04.006. Epub 2015 May 8. Review.

24.

Deep Sequencing of HIV-1 in Cerebrospinal Fluid.

Tong CY, Costelloe S, Hubb J, Mullen J, O'Shea S, Marta M, Kulasegaram R, Rackstraw S.

Clin Infect Dis. 2015 Sep 15;61(6):1022-5. doi: 10.1093/cid/civ417. Epub 2015 May 28.

PMID:
26021989
25.

Do neutralising antibodies against exogenous interferon-beta inhibit endogenous signalling pathways?

Fine D, Dattani A, Moreira I, Giovannoni G, Marta M.

Mult Scler Relat Disord. 2015 Jan;4(1):88-91. doi: 10.1016/j.msard.2014.11.007. Epub 2014 Nov 28.

PMID:
25787060
26.

The role of infections in Behçet disease and neuro-Behçet syndrome.

Marta M, Santos E, Coutinho E, Silva AM, Correia J, Vasconcelos C, Giovannoni G.

Autoimmun Rev. 2015 Jul;14(7):609-15. doi: 10.1016/j.autrev.2015.02.009. Epub 2015 Mar 11. Review.

PMID:
25769946
27.

Varicella-zoster virus encephalitis mimicking toxoplasmosis relapse.

Marques IB, Flanagan S, Noble H, Giovannoni G, Marta M.

Neurol Neuroimmunol Neuroinflamm. 2015 Feb 12;2(2):e74. doi: 10.1212/NXI.0000000000000074. eCollection 2015 Apr. No abstract available.

28.

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J, Bestwick JP, Meier UC, Marta M, Dalla Costa G, Runia T, Evdoshenko E, Lazareva N, Thouvenot E, Iaffaldano P, Direnzo V, Khademi M, Piehl F, Comabella M, Sombekke M, Killestein J, Hegen H, Rauch S, D'Alfonso S, Alvarez-Cermeño JC, Kleinová P, Horáková D, Roesler R, Lauda F, Llufriu S, Avsar T, Uygunoglu U, Altintas A, Saip S, Menge T, Rajda C, Bergamaschi R, Moll N, Khalil M, Marignier R, Dujmovic I, Larsson H, Malmestrom C, Scarpini E, Fenoglio C, Wergeland S, Laroni A, Annibali V, Romano S, Martínez AD, Carra A, Salvetti M, Uccelli A, Torkildsen Ø, Myhr KM, Galimberti D, Rejdak K, Lycke J, Frederiksen JL, Drulovic J, Confavreux C, Brassat D, Enzinger C, Fuchs S, Bosca I, Pelletier J, Picard C, Colombo E, Franciotta D, Derfuss T, Lindberg R, Yaldizli Ö, Vécsei L, Kieseier BC, Hartung HP, Villoslada P, Siva A, Saiz A, Tumani H, Havrdová E, Villar LM, Leone M, Barizzone N, Deisenhammer F, Teunissen C, Montalban X, Tintoré M, Olsson T, Trojano M, Lehmann S, Castelnovo G, Lapin S, Hintzen R, Kappos L, Furlan R, Martinelli V, Comi G, Ramagopalan SV, Giovannoni G.

Mult Scler. 2015 Jul;21(8):1013-24. doi: 10.1177/1352458514568827. Epub 2015 Feb 13.

PMID:
25680984
29.

Mononeuritis multiplex as the first presentation of refractory sarcoidosis responsive to etanercept.

Marques IB, Giovannoni G, Marta M.

BMC Neurol. 2014 Dec 11;14:237. doi: 10.1186/s12883-014-0237-5.

30.

Thrombosis of abdominal aorta in congenital afibrinogenemia: case report and review of literature.

Sartori MT, Milan M, de Bon E, Fadin M, Pesavento R, Zanon E.

Haemophilia. 2015 Jan;21(1):88-94. doi: 10.1111/hae.12507. Epub 2014 Nov 24. Review. Erratum in: Haemophilia. 2015 May;21(3):405. Teresa, S M [corrected to Sartori, M T]; Marta, M [corrected to Milan, M]; Emiliano, D B [corrected to de Bon, E]; Mariangela, F [corrected to Fadin, M]; Raffaele, P [corrected to Pesavento, R]; Ezio, Z [corrected to Zanon, E].

PMID:
25421938
32.

Proton radii of (12-17)B define a thick neutron surface in ¹⁷B.

Estradé A, Kanungo R, Horiuchi W, Ameil F, Atkinson J, Ayyad Y, Cortina-Gil D, Dillmann I, Evdokimov A, Farinon F, Geissel H, Guastalla G, Janik R, Kimura M, Knöbel R, Kurcewicz J, Litvinov YA, Marta M, Mostazo M, Mukha I, Nociforo C, Ong HJ, Pietri S, Prochazka A, Scheidenberger C, Sitar B, Strmen P, Suzuki Y, Takechi M, Tanaka J, Tanihata I, Terashima S, Vargas J, Weick H, Winfield JS.

Phys Rev Lett. 2014 Sep 26;113(13):132501. Epub 2014 Sep 23.

PMID:
25302882
33.

Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats.

Castelo-Branco G, Stridh P, Guerreiro-Cacais AO, Adzemovic MZ, Falcão AM, Marta M, Berglund R, Gillett A, Hamza KH, Lassmann H, Hermanson O, Jagodic M.

Neurobiol Dis. 2014 Nov;71:220-33. doi: 10.1016/j.nbd.2014.08.019. Epub 2014 Aug 19.

34.

First direct measurement of the 2H(α,γ)6Li cross section at big bang energies and the primordial lithium problem.

Anders M, Trezzi D, Menegazzo R, Aliotta M, Bellini A, Bemmerer D, Broggini C, Caciolli A, Corvisiero P, Costantini H, Davinson T, Elekes Z, Erhard M, Formicola A, Fülöp Z, Gervino G, Guglielmetti A, Gustavino C, Gyürky G, Junker M, Lemut A, Marta M, Mazzocchi C, Prati P, Rossi Alvarez C, Scott DA, Somorjai E, Straniero O, Szücs T; LUNA Collaboration.

Phys Rev Lett. 2014 Jul 25;113(4):042501. Epub 2014 Jul 21.

35.

Pulmonary function and exercise tolerance are related to disease severity in pre-dialytic patients with chronic kidney disease: a cross-sectional study.

Faria Rde S, Fernandes N, Lovisi JC, Reboredo Mde M, Marta MS, Pinheiro Bdo V, Bastos MG.

BMC Nephrol. 2013 Sep 4;14:184. doi: 10.1186/1471-2369-14-184.

36.

Biomarker report from the phase II lamotrigine trial in secondary progressive MS - neurofilament as a surrogate of disease progression.

Gnanapavan S, Grant D, Morant S, Furby J, Hayton T, Teunissen CE, Leoni V, Marta M, Brenner R, Palace J, Miller DH, Kapoor R, Giovannoni G.

PLoS One. 2013 Aug 1;8(8):e70019. doi: 10.1371/journal.pone.0070019. Print 2013.

37.

Anti-MOG antibodies are under polygenic regulation with the most significant control coming from the C-type lectin-like gene locus.

Flytzani S, Stridh P, Guerreiro-Cacais AO, Marta M, Hedreul MT, Jagodic M, Olsson T.

Genes Immun. 2013 Oct;14(7):409-19. doi: 10.1038/gene.2013.33. Epub 2013 Jun 20.

PMID:
23784360
38.

Management of a solitary tongue nodule.

Guglielmo PC, Marta M, Giorgia C, Claudia A, Giulia P, Eugenio P, Luigi V, Miriam G.

Indian J Dermatol. 2013 May;58(3):246. doi: 10.4103/0019-5154.110889. No abstract available.

39.

Patients with prehypertension - do we have enough evidence to treat them?

Marta M, Zanchetti A, Wong ND, Malyszko J, Rysz J, Banach M.

Curr Vasc Pharmacol. 2014;12(4):586-97. Review.

PMID:
23627984
40.

First direct measurement of the 17O(p,γ)18F reaction cross section at Gamow energies for classical novae.

Scott DA, Caciolli A, Di Leva A, Formicola A, Aliotta M, Anders M, Bemmerer D, Broggini C, Campeggio M, Corvisiero P, Elekes Z, Fülöp Z, Gervino G, Guglielmetti A, Gustavino C, Gyürky G, Imbriani G, Junker M, Laubenstein M, Menegazzo R, Marta M, Napolitani E, Prati P, Rigato V, Roca V, Somorjai E, Salvo C, Straniero O, Strieder F, Szücs T, Terrasi F, Trezzi D; LUNA Collaboration.

Phys Rev Lett. 2012 Nov 16;109(20):202501. Epub 2012 Nov 13.

PMID:
23215474
41.

Disease modifying drugs in multiple sclerosis: mechanisms of action and new drugs in the horizon.

Marta M, Giovannoni G.

CNS Neurol Disord Drug Targets. 2012 Aug;11(5):610-23. Review.

PMID:
22583439
42.

Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients.

Leite MI, Coutinho E, Lana-Peixoto M, Apostolos S, Waters P, Sato D, Melamud L, Marta M, Graham A, Spillane J, Villa AM, Callegaro D, Santos E, da Silva AM, Jarius S, Howard R, Nakashima I, Giovannoni G, Buckley C, Hilton-Jones D, Vincent A, Palace J.

Neurology. 2012 May 15;78(20):1601-7. doi: 10.1212/WNL.0b013e31825644ff. Epub 2012 May 2.

43.

Vitamin D deficiency--do we follow our own advice?

Dobson R, Meier UC, Marta M, Ramagopalan S, Giovannoni G.

Clin Med (Lond). 2011 Dec;11(6):521-3.

44.

Development of resistance to biologic therapies with reference to IFN-β.

Farrell RA, Marta M, Gaeguta AJ, Souslova V, Giovannoni G, Creeke PI.

Rheumatology (Oxford). 2012 Apr;51(4):590-9. doi: 10.1093/rheumatology/ker445. Epub 2012 Jan 18. Review.

PMID:
22258390
45.

2-DE proteomic analysis of HSP70 in mollusc Chamelea gallina.

Jurgen F, Valerio M, Roberto R, Paolo SG, Marta M.

Fish Shellfish Immunol. 2011 Feb;30(2):739-43. doi: 10.1016/j.fsi.2010.12.007. Epub 2010 Dec 17.

PMID:
21168507
46.

Binding affinity of triphenyl acrylonitriles to estrogen receptors: quantitative structure-activity relationships.

Bolboacă SD, Marta MM, Jäntschi L.

Folia Med (Plovdiv). 2010 Jul-Sep;52(3):37-45.

PMID:
21053672
47.

Fine-mapping resolves Eae23 into two QTLs and implicates ZEB1 as a candidate gene regulating experimental neuroinflammation in rat.

Stridh P, Thessen Hedreul M, Beyeen AD, Adzemovic MZ, Laaksonen H, Gillett A, Ockinger J, Marta M, Lassmann H, Becanovic K, Jagodic M, Olsson T.

PLoS One. 2010 Sep 15;5(9):e12716. doi: 10.1371/journal.pone.0012716.

48.

Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?

Maghzi AH, Marta M, Bosca I, Etemadifar M, Dobson R, Maggiore C, Giovannoni G, Meier UC.

Pathophysiology. 2011 Feb;18(1):13-20. doi: 10.1016/j.pathophys.2010.04.003. Epub 2010 Jun 9.

PMID:
20538440
49.

TNF production in macrophages is genetically determined and regulates inflammatory disease in rats.

Gillett A, Marta M, Jin T, Tuncel J, Leclerc P, Nohra R, Lange S, Holmdahl R, Olsson T, Harris RA, Jagodic M.

J Immunol. 2010 Jul 1;185(1):442-50. doi: 10.4049/jimmunol.0904101. Epub 2010 May 26.

50.

Census tract socioeconomic and physical environment and cardiovascular mortality in the Region of Madrid (Spain).

Domínguez-Berjón MF, Gandarillas A, Segura del Pozo J, Zorrilla B, Soto MJ, López L, Duque I, Marta MI, Abad I.

J Epidemiol Community Health. 2010 Dec;64(12):1086-93. doi: 10.1136/jech.2008.085621. Epub 2009 Dec 8.

PMID:
19996355

Supplemental Content

Support Center